Demo Sign up Log In

Vertex Pharmaceuticals (VRTX)

Cost of Revenue

$489.20M

Quarterly · Period ending: Jun 30, 2026 · USD

VRTX Cost of Revenue

Latest reported$489.20Mperiod endingJun 30, 2026

Latest reported$489.20Mperiod endingJun 30, 2026

VRTX Quarterly Cost of Revenue ($0.00 → $489.20M)

Quarterly cost of revenue

High-resolution chart · PNG

VRTX cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Cost of Revenue — Quarterly (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2001	921,000
Mar 31, 2001	837,000
Dec 31, 2000	7,362,000
Sep 30, 2000	-1,167,000
Jun 30, 2000	-1,010,000
Mar 31, 2000	-1,103,000
Dec 31, 1999	-1,000,000
Sep 30, 1999	-1,000,000
Jun 30, 1999	-200,000
Mar 31, 1999	-1,200,000
Dec 31, 1998	-1,400,000
Sep 30, 1998	-1,100,000
Jun 30, 1998	-1,100,000
Mar 31, 1998	-900,000
Dec 31, 1997	-1,000,000
Sep 30, 1997	-1,000,000
Jun 30, 1997	-800,000
Mar 31, 1997	-800,000
Dec 31, 1996	-700,000
Sep 30, 1996	-800,000
Jun 30, 1996	-900,000
Mar 31, 1996	-800,000
Dec 31, 1995	-1,000,000
Sep 30, 1995	-1,000,000
Jun 30, 1995	-700,000
Mar 31, 1995	-1,000,000
Dec 31, 1994	-1,000,000
Sep 30, 1994	-800,000
Jun 30, 1994	-900,000
Mar 31, 1994	-900,000
Dec 31, 1993	-1,100,000
Sep 30, 1993	-900,000
Jun 30, 1993	-900,000
Mar 31, 1993	-800,000
Dec 31, 1992	-700,000
Sep 30, 1992	-700,000
Jun 30, 1992	2,000,000
Mar 31, 1992	-600,000
Dec 31, 1991	-500,000
Sep 30, 1991	-400,000
Jun 30, 1991	-500,000
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.